Carson Allaria Wealth Management, Ltd. Amgen Inc Transaction History

Carson Allaria Wealth Management, Ltd.

$180 Million
Q2 2025

A detailed history of Carson Allaria Wealth Management, Ltd. transactions in Amgen Inc stock. As of the latest transaction made, Carson Allaria Wealth Management, Ltd. holds 701 shares of AMGN stock, worth $214,912. This represents 0.11% of its overall portfolio holdings.

Number of Shares

701

Previous 700 0.14%

Holding current value

$214,912

Previous $218,000 10.55%

% of portfolio

0.11%

Previous 0.13%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	BUY	$262.28 - $309.85 $262 - $309	1 Added 0.14%	701 $195,000
Q4 2024 Jan 27, 2025	SELL	$258.78 - $328.31 $17,079 - $21,668	-66 Reduced 8.62%	700 $182,000
Q3 2024 Oct 21, 2024	SELL	$309.38 - $337.38 $18,872 - $20,580	-61 Reduced 7.38%	766 $246,000
Q2 2024 Jul 22, 2024	SELL	$262.75 - $319.31 $23,910 - $29,057	-91 Reduced 9.91%	827 $258,000
Q1 2024 May 07, 2024	SELL	$268.87 - $324.56 $36,028 - $43,491	-134 Reduced 12.74%	918 $261,000
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $10,739 - $12,115	-42 Reduced 3.84%	1,052 $302,000
Q3 2023 Nov 09, 2023	SELL	$218.65 - $271.46 $2,186 - $2,714	-10 Reduced 0.91%	1,094 $294,000
Q1 2023 Apr 26, 2023	BUY	$225.79 - $275.2 $1,354 - $1,651	6 Added 0.55%	1,104 $266,000
Q4 2022 Feb 06, 2023	BUY	$229.03 - $291.01 $25,651 - $32,593	112 Added 11.36%	1,098 $288,000
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $673 - $759	3 Added 0.31%	986 $222,000
Q1 2022 May 05, 2022	BUY	$219.27 - $242.57 $2,631 - $2,910	12 Added 1.24%	983 $238,000
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $193,112 - $220,999	971 New	971 $219,000

Others Institutions Holding AMGN

# of Institutions

3,285

Shares Held

426M

Call Options Held

8.07M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $164B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carson Allaria Wealth Management, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Carson Allaria Wealth Management, Ltd. with notifications on news.

Account

Carson Allaria Wealth Management, Ltd. Amgen Inc Transaction History